{"DataElement":{"publicId":"2714666","version":"1","preferredName":"Axillary Lymph Node Clinical Disease N Stage Status","preferredDefinition":"Manifestation of malignant disease in the axillary lymph nodes as determined by the clinical N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed. [Manually-curated]","longName":"AXIL_LN_CLIN_N_STAT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2714664","version":"1","preferredName":"Axillary Lymph Node Clinical Disease Status","preferredDefinition":"information related the pathologic response, the quantitative improvement of the course or manifestation of disease related to a treatment, in the axillary lymph node, the rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue in the armpit area._Having to do with the examination and treatment of patients._A condition or state at a particular time._A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown._Having determined the value, significance, or extent of.","longName":"AXIL_LN_CLIN_STAT","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2532888","version":"1","preferredName":"Axillary Lymph Node","preferredDefinition":"(AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.:A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.","longName":"C13351:C12745","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Axillary","conceptCode":"C13351","definition":"Pertaining to the armpit area, including the lymph nodes that are located there.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D008A1-C51C-574F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-27","modifiedBy":"ONEDATA","dateModified":"2006-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2714662","version":"1","preferredName":"Clinical Diseases and Disorders Assessed Status","preferredDefinition":"Having to do with the examination and treatment of patients.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.:Having determined the value, significance, or extent of.:A condition or state at a particular time.","longName":"C25398:C2991:C25217:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"418EFB72-9EAA-7046-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-18","modifiedBy":"ONEDATA","dateModified":"2007-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"418EFB72-9EBB-7046-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018464","version":"2","preferredName":"Breast Tumor Clinical N Stage","preferredDefinition":"the clinical N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BRST_TUMOR_C_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"NO REGIONAL LYMPH NODE METASTASIS","ValueMeaning":{"publicId":"2559539","version":"1","preferredName":"NO REGIONAL LYMPH NODE METASTASIS","longName":"2559539","preferredDefinition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA549B-DAF7-2848-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N1","valueDescription":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","ValueMeaning":{"publicId":"2559202","version":"1","preferredName":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","longName":"2559202","preferredDefinition":"METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B44F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA549B-DAF8-2848-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N2","valueDescription":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis","ValueMeaning":{"publicId":"2576674","version":"1","preferredName":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis","longName":"2576674","preferredDefinition":"Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis * [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination or grossly visible pathologically.]","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA549B-DAF9-2848-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N3","valueDescription":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","ValueMeaning":{"publicId":"2576675","version":"1","preferredName":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","longName":"2576675","preferredDefinition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3a TNM Finding v6 and v7","conceptCode":"C73353","definition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F890-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA549B-DAFA-2848-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"NX","valueDescription":"REGIONAL LYMPH NODES CANNOT BE ASSESSED (E.G., PREVIOUSLY REMOVED)","ValueMeaning":{"publicId":"2559964","version":"1","preferredName":"REGIONAL LYMPH NODES CANNOT BE ASSESSED (E.G., PREVIOUSLY REMOVED)","longName":"2559964","preferredDefinition":"Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cNX TNM Finding v6 and v7","conceptCode":"C73346","definition":"Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B749-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA549B-DAFB-2848-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N2a","valueDescription":"Metastasis in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures","ValueMeaning":{"publicId":"2576680","version":"1","preferredName":"Metastasis in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures","longName":"2576680","preferredDefinition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2a TNM Finding v6 and v7","conceptCode":"C73350","definition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F895-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA6421-0290-284C-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N2b","valueDescription":"Metastasis only in clinically apparent* ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis","ValueMeaning":{"publicId":"2576679","version":"1","preferredName":"Metastasis only in clinically apparent* ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis","longName":"2576679","preferredDefinition":"Breast cancer with metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2b TNM Finding v7","conceptCode":"C88369","definition":"Breast cancer with metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F894-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA6421-0294-284C-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N3a","valueDescription":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","ValueMeaning":{"publicId":"2576675","version":"1","preferredName":"Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me","longName":"2576675","preferredDefinition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3a TNM Finding v6 and v7","conceptCode":"C73353","definition":"Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F890-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA6421-0298-284C-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N3b","valueDescription":"Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)","ValueMeaning":{"publicId":"2576677","version":"1","preferredName":"Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)","longName":"2576677","preferredDefinition":"Breast cancer with metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3b TNM Finding v6 and v7","conceptCode":"C73354","definition":"Breast cancer with metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F892-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA6421-029B-284C-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N3c","valueDescription":"Metastasis in ipsilateral supraclavicular lymph node(s)","ValueMeaning":{"publicId":"2576676","version":"1","preferredName":"Metastasis in ipsilateral supraclavicular lymph node(s)","longName":"2576676","preferredDefinition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN3c TNM Finding v6 and v7","conceptCode":"C49007","definition":"Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F891-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"REEVESD","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03AA6421-029F-284C-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"N1a","valueDescription":"N1a Stage Finding","ValueMeaning":{"publicId":"5654386","version":"1","preferredName":"N1a Stage Finding","longName":"5654386","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1a TNM Finding","conceptCode":"C48707","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DEFD19-9CCD-7921-E053-F662850AFEAD","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BAF53EF-3FE4-1B02-E053-F662850A71C2","beginDate":"2017-10-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-10-16","modifiedBy":"ONEDATA","dateModified":"2017-10-16","deletedIndicator":"No"},{"value":"N1mi","valueDescription":"N1mi Stage Finding","ValueMeaning":{"publicId":"3202517","version":"1","preferredName":"N1mi Stage Finding","longName":"3202517","preferredDefinition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pN1mi TNM Finding v7","conceptCode":"C88353","definition":"Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49A5-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7AC43-B72C-5A12-E053-F662850A4315","beginDate":"2019-03-12","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":"N0 (i-)","valueDescription":"N0 (i-) Stage Finding","ValueMeaning":{"publicId":"3202525","version":"1","preferredName":"N0 (i-) Stage Finding","longName":"3202525","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i-) TNM Finding","conceptCode":"C95921","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4ACD-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7AC43-B736-5A12-E053-F662850A4315","beginDate":"2019-03-12","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":"N0 (i+)","valueDescription":"N0 (i+) Stage Finding","ValueMeaning":{"publicId":"3202524","version":"1","preferredName":"N0 (i+) Stage Finding","longName":"3202524","preferredDefinition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i+) TNM Finding","conceptCode":"C95922","definition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4AA8-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7AC43-B741-5A12-E053-F662850A4315","beginDate":"2019-03-12","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03AA549B-DAE2-2848-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"MORENOC","dateModified":"2019-03-12","changeDescription":"Updated permissible values.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812582","version":"1","longName":"P1_CPT_BCNU_RD","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Clinical Axillary Lymph Node","type":"Preferred Question Text","description":"Clinical Axillary Lymph Node Status","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"41902472-CC6C-1952-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-18","modifiedBy":"LUY","dateModified":"2013-09-13","changeDescription":"Curated to support Duke University adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}